Hematology Analyzer Market

Hematology Analyzer Market Overview

Global Hematology Analyzer demand is projected to be valued at US$ 2.19 Billion in 2022, forecast to grow at a CAGR of 7.47% to be valued at US$ 4.5 Billion from 2022 to 2032. Growth is attributed to the rising demand for renovation projects and development in residential and commercial construction.

Hematology is the part of medical sciences mainly related to the research, diagnosis, and treatment of blood-related disorders. Hematology analysers are specific and electronic systems that count red cells, leucocytes, and platelets in the blood, and also determine the level of haemoglobin and haematocrit in blood. Hematology technology has gained pace in a relatively short duration of time.

In the conventional system, the process of CBC (complete blood count) was performed manually by a specialist in front of a microscope. Haemoglobin can also be identified manually by applying a cyanmethemoglobin method, which is a slow and time-consuming process.

The new and technologically advanced hematology analyser is equipped with the latest technologies that it can treat up to hundreds of samples in an hour. Modular structures and improvements in automation indicate that the new systems can be built in such a way that they can serve numerous analysers, slide strainers, and archiving facilities.

Which are Some Prominent Drivers Spearheading Hematology Analyzer Market Growth?

The higher preference for automated hematology instruments, along with increasing technological advancements, and the combination of basic flow-cytometry techniques in automated hematology analyzers are some of the key constituents that are propelling the demand for hematology analyzers in the market.

Besides, the growing demand for highly efficient hematology analyzers, in addition to high-sensitivity point-of-care (POC) in hematology testing is also improving the growth in demand of the global hematology analyzer market. However, strict and time-consuming regulative policies for hematology and laboratory instruments also impeded the market growth of hematology analyzers.

What are the Challenges Faced by the Hematology Analyzer Industry?

The higher cost of hematology analyzers and threats of newcomers and stiff competition among existing players are likely to hinder the growth of the global hematology analyzers market.  Furthermore, the protection and quality of hematology analyzers are likely to be a hurdle to the growth of the global hematology analyzer market.

Why is Asia-Pacific Emerging as an Opportunistic Hematology Analyzer Market?

APEJ is anticipated to witness high growth in the global Hematology Analyzer market.  Also, increasing focus on emerging markets, such as India and China, could also open up opportunities for new players in the global hematology analyzer. 

Moreover, raising awareness about better healthcare and a large patient population base is also driving the growth of the hematology analyzer & reagent market in Asia. 

Nikhil Kaitwade

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to the Growth of the Hematology Analyzer Market?

The demand for innovative and entirely automated hematology analyzers is anticipated to upsurge owing to the increase in the prevalence of the target population necessitating hematological tests, augmented focus on technological advancements, and the shift towards automation in hematology analyzers.

Why does North America Hold a Significant Share in the Hematology Analyzer Market?

North America dominates the global hematology analyzer, backed by the swelling adoption of automated hematology instruments by diagnostics laboratories in this province. The demand is largely growing across the professional healthcare settings to treat the mounting patient population.

Besides, an increase in the occurrence of various blood-related disorders such as anemia, sickle cell disease, and thalassemia, especially in the US and Canada as well as the increasing necessity for hematology testing is enhancing the demand for hematology analyzers and consumables.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Market Competition

Some of the key participants present in the global demand of the Hematology Analyzer market include Sysmex Corporation, Abbott Laboratories, Fisher Scientific, Beckman Coulter, Inc., Balio Diagnostics, Bio-Rad Laboratories, Inc., Hycel, Mindray Medical International Limited, Spinreact, Siemens Healthcare, HORIBA, Ltd., Dymind Biotech, and NIHON KOHDEN CORPORATION among others. 

• Abbott had recently developed the Sekisui CP3000 coagulation system, a fully automated analyzer that tests bleeding and clotting function in the blood. This system is now available in Europe, the Middle East, and the Asia Pacific.

Report Scope

Key Segments Profiled in the Hematology Analyzer Industry Survey

By Number of Parameters:

• Hematology Analyzers Up to 10 Parameters
• Hematology Analyzers from 10-30 Parameters
• Hematology Analyzers Above 30 Parameters

By End Use Industries:

• Hematology Analyzers for Clinical Laboratories
• Hematology Analyzers for Research Laboratories

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East and Africa